Predict your next investment

MDSi company logo
COMPUTER HARDWARE & SERVICES | IT Services / IT Solutions & Software Development
mdsiinc.com

See what CB Insights has to offer

Founded Year

1990

About MDSi

MDSi is an IT solutions partner with a comprehensive portfolio of products, professional services and supply chain solutions.

MDSi Headquarter Location

6225 Shiloh Rd

Alpharetta, Georgia, 30005,

United States

800-874-9850

Latest MDSi News

Patients with major depressive episode, suicidality face significant care barriers

Oct 5, 2021

Disclosures: Wilkinson reports having received funding for the conduct of clinical trials administered through Yale University from Janssen, Oui Therapeutics and Sage Therapeutics, as well as consulting fees from Biohaven, Janssen, Oui Therapeutics and Sage Therapeutics. Please see the study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio U.S. adults with a major depressive episode and suicidal ideation or behavior with intent had higher mental health care resource utilization and more barriers to care than those with only a major depressive episode. “We were interested in looking at the real-world patterns of health care delivery among individuals with depression and suicidal ideation,” co-author Samuel T. Wilkinson, MD, assistant professor in the department of psychiatry at Yale School of Medicine in Connecticut, told Healio Psychiatry. “This is a population that has historically been excluded from most antidepressant clinical trials. “We were able to confirm (which many practicing psychiatrists already knew) that these individuals represent the most severely ill end of the spectrum of individuals with depression,” Wilkinson added. “As such, they use a very large amount of health care compared with individuals with depression without suicidal ideation.” Wilkinson and colleagues aimed to assess the incremental mental health care resource utilization and barriers to receipt of mental health services among adults with a major depressive episode and suicidal ideation or behavior with intent. They used data from participants of the 2017 National Survey on Drug Use and Health to pinpoint three cohorts. These included individuals with a major depressive episode defined via DSM-5 criteria with suicidal ideation or behavior with intent (MDSI) (n = 572), those with a major depressive episode (n = 2,513) and those without a major depressive episode (36,903). The researchers used logistic regression models to compare mental health care resource utilization and barriers to receipt of mental health services among cohorts. Results showed significantly increased risk for receipt of mental health-related inpatient care , outpatient care, prescription medications and any treatment for the MDSI cohort compared with the major depressive episode cohort and the non-major depressive episode cohort. The MDSI cohort vs. the major depressive episode cohort significantly more often reported barriers to receipt of mental health services, with the largest differences between cohorts associated with fear of negative impact. A total of 30.6% of the MDSI cohort and 47% of the major depressive episode cohort received no past-year mental health treatment. “Despite the fact that individuals with depression and suicidal ideation have a high rate of use of health care resources, there are clearly some gaps where they should be receiving more care,” Wilkinson said. “For instance, among individuals with depression and suicidal ideation, only 69.4% reported any mental health care in the prior year. “I would hope that this figure could be closer to 100%, because it’s not normal to be having suicidal thoughts,” Wilkinson added. According to Wilkinson, a study limitation and a potential area for future study included that the researchers did not look closely at the relationship between substance abuse, depression and suicidal ideation, and how substance abuse might have also affected this higher rate of health care utilization. Read more about

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

MDSi Patents

MDSi has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/2/2001

2/3/2009

Manufacturing, Production and manufacturing, Supply chain management, Copyright length, Fantaserye and telefantasya

Grant

Application Date

4/2/2001

Grant Date

2/3/2009

Title

Related Topics

Manufacturing, Production and manufacturing, Supply chain management, Copyright length, Fantaserye and telefantasya

Status

Grant

MDSi Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MDSi Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.